<DOC>
	<DOCNO>NCT01001481</DOCNO>
	<brief_summary>The primary objective treatment review feedback program quantify risk status medication adherence cohort Australian patient diagnose schizophrenia .</brief_summary>
	<brief_title>Schizophrenia Treatment Adherence Investigation ( STAI )</brief_title>
	<detailed_description>The primary objective treatment review feedback program quantify risk status medication adherence cohort Australian patient diagnose schizophrenia . Observational study - study drug administer</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<criteria>Clinical diagnosis schizophrenia schizoaffective disorder accord DSMIV Currently treat outpatient clinic Able provide inform consent Concurrent enrolment clinical trial acceptable Have complete question Drug Attitude Inventory ( DAI10 ) Medication Adherence Rating Scale ( MARS ) survey</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Treatment review</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Observational</keyword>
	<keyword>Prospective study</keyword>
	<keyword>Australia</keyword>
</DOC>